Used primarily in the development of selective estrogen receptor modulators (SERMs), this compound exhibits strong affinity for estrogen receptors, making it valuable in the treatment of hormone-dependent conditions. It has been investigated for use in breast cancer therapy due to its ability to block estrogen activity in breast tissue. Additionally, it shows potential in managing osteoporosis by mimicking estrogen’s beneficial effects on bone density without stimulating uterine tissue. Its tissue-selective action reduces the risk of certain side effects commonly associated with traditional hormone therapies. Also explored for use in diagnostic imaging due to its binding specificity, aiding in the detection of estrogen receptor-positive tumors.